Enko Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
2ndary - Private
- Investors
-
16
Enko General Information
Description
Developer of sustainable small molecule technologies designed for farmers to protect their crops from pests and disease. The company uses Deoxyribonucleic Acid (DNA)-encoded libraries, artificial intelligence, structure-based design, and machine learning to find and select the right treatments for the right targets faster and more effectively than traditional research and development methods, enabling farmers with new tools to grow and protect their crops successfully and sustainably.
Contact Information
Website
www.enko.agCorporate Office
- 62 Maritime Drive
- Mystic, CT 06355
- United States
Corporate Office
- 62 Maritime Drive
- Mystic, CT 06355
- United States
Enko Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 4. Later Stage VC (Series C) | 30-Nov-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 30-Jun-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 19-Apr-2019 | $15M | $21M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 30-May-2017 | $6M | $6M | Completed | Startup |
Enko Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 9,999,998 | $0.000100 | $1.5 | $1.5 | 1x | $1.5 | 14.73% | |
| Series A | 6,000,000 | $0.000100 | $1 | $1 | 1x | $1 | 8.84% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Enko Comparisons
Industry
Financing
Details
Enko Competitors (24)
One of Enko’s 24 competitors is Provivi, a Private Equity-Backed company based in Santa Monica, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Provivi | Private Equity-Backed | Santa Monica, CA | ||||
| Bayer CropScience United States | Formerly VC-backed | Whippany, NJ | ||||
| Crop Enhancement | Venture Capital-Backed | San Jose, CA | ||||
| Syngenta | Formerly Accelerator/Incubator backed | Basel, Switzerland | ||||
| Vive Crop Protection | Venture Capital-Backed | Mississauga, Canada |
Enko Patents
Enko Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026097031-A1 | Process for manufacturing 6-perfluorophenyl benzoxazinones | Pending | 04-Nov-2024 | ||
| WO-2024238566-A2 | Process for manufacturing 6-perfluorophenyl benzoxazinones | Inactive | 15-May-2023 | ||
| WO-2024238566-A3 | Process for manufacturing 6-perfluorophenyl benzoxazinones | Inactive | 15-May-2023 | ||
| US-20260256143-A1 | Herbicidal composition and method for controlling weeds | Pending | 14-Mar-2023 | ||
| WO-2024192154-A1 | Herbicidal composition and method for controlling weeds | Inactive | 14-Mar-2023 | A01N43/84 |
Enko Signals
Enko Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Akroyd LLC | Corporation | Minority | ||
| DYDX | Venture Capital | Minority | ||
| Endeavor8 | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Alumni Ventures | Venture Capital | Minority |
Enko FAQs
-
When was Enko founded?
Enko was founded in 2017.
-
Where is Enko headquartered?
Enko is headquartered in Mystic, CT.
-
What is the size of Enko?
Enko has 50 total employees.
-
What industry is Enko in?
Enko’s primary industry is Agricultural Chemicals.
-
Is Enko a private or public company?
Enko is a Private company.
-
What is Enko’s current revenue?
The current revenue for Enko is .
-
How much funding has Enko raised over time?
Enko has raised $151M.
-
Who are Enko’s investors?
Akroyd LLC, DYDX, Endeavor8, , and Alumni Ventures are 5 of 16 investors who have invested in Enko.
-
Who are Enko’s competitors?
Provivi, Bayer CropScience United States, Crop Enhancement, Syngenta, and Vive Crop Protection are some of the 24 competitors of Enko.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process